According to the settlement agreement, Burlington Labs will pay the Vermont Medicaid program $6.75 million in a seven-year period. In a statement by the attorney general’s office, the extended payment contract gives Burlington Labs the chance to continue operations while also compensating the state Medicaid program. The settlement also requires Burlington Labs to enter into a corporate integrity agreement with the state.
The attorney general’s office investigated Burlington Labs after the company was accused of submitting false claims and receiving overpayments from the state Medicaid program. According to investigators, in January 2015, Burlington Labs received more than $12 million in reimbursements from Medicaid, compared to the $10 million it received in total from the program during the previous five years, according to the article.
More articles on legal and regulatory issues:
Metro Health secures $1M settlement against former executive
Former West Jefferson hospital CFO cellphone records subpoenaed in ongoing audit
FTC sides with Cabell Huntington, St. Mary’s to withhold merger documents
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
